Home » Topics » Disease categories and therapies » Immune

Immune
RSS

PowderJect and Glaxo Wellcome enter DNA vaccine collaboration

March 10, 1998

Boston Life Sciences licenses BCLx-gamma gene from Harvard

March 10, 1998

Zenapax approved in Switzerland

March 5, 1998

Vaccines for group B meningococcal infection disclosed

March 4, 1998

Cholera toxin enhances transcutaneous delivery, enabling development of needle-free vaccines

March 4, 1998

NIH offers potential tuberculosis vaccine technology for licensing

March 3, 1998

NIH offers new technology for licensing

March 2, 1998

First potent and selective CB2 receptor antagonist developed at Sanofi

Feb. 24, 1998

Pneumovax does not prevent pneumonia in middle-aged and elderly immunocompetent patients

Feb. 19, 1998

Cytokine-inducing profile of imiquimod and two analogues characterized in monkeys

Feb. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...